| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5733939 | Journal of Surgical Research | 2016 | 9 Pages |
Abstract
Our studies have showed that both inhibitors of PI3K/mTOR and RAS/ERK signaling are potentially effective antihepatocellular carcinoma drugs especially in treating sorafenib-resistant hepatocellular carcinoma.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Chang-Hao MMed, Xiang MMed, Hong-Wei MD,